Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook
10:35pm, Tuesday, 14'th Jan 2025
Eli Lilly (LLY) shares could remain under the microscope on Wednesday after falling sharply in trade on Tuesday as the pharmaceutical giant lowered its 2024 full-year revenue forecast.
Eli Lilly and Company (LLY) CEO Dave Ricks presents at 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
07:58pm, Tuesday, 14'th Jan 2025
Eli Lilly and Company (NYSE:LLY ) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 5:15 PM ET Company Participants Dave Ricks - Chairman and CEO Conference Call Participants Chris Schott
Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz
05:51pm, Tuesday, 14'th Jan 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk how to play Eli Lilly's stock right now.
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens
05:20pm, Tuesday, 14'th Jan 2025
Major U.S. equities indexes were mixed on Tuesday after the latest Producer Price Index (PPI) data showed a lighter-than-expected uptick in wholesale prices for December. The soft PPI report helped al
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
04:31pm, Tuesday, 14'th Jan 2025
Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health Care Conference.
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
04:00pm, Tuesday, 14'th Jan 2025
J&J announces a big deal to acquire neuroscience company ITCI for $14.6 billion, while Lilly and GSK announce smaller deals.
Eli Lilly Stock Slumps on Lowered Sales Forecast
02:20pm, Tuesday, 14'th Jan 2025
Eli Lilly (LLY) shares tumbled Tuesday after the drugmaker lowered its revenue forecast for the 2024 fiscal year.
Eli Lilly stumbles as weight-loss drug sales less than expected
02:00pm, Tuesday, 14'th Jan 2025
Shares in Eli Lilly and Co fell 6.4% after the drugmaker said sales of its Mounjaro and Zepbound weight-loss medications grew more slowly than it had expected. CEO David Ricks said the US market
Final Trades: Reddit, Delta, Thermo Fisher and Eli Lilly
01:40pm, Tuesday, 14'th Jan 2025
The Investment Committee give you their top stocks to watch for the second half.
Eli Lilly lowers FY revenue forecast as weight loss drug sales fall short
01:19pm, Tuesday, 14'th Jan 2025
Shares in Eli Lilly and Co (NYSE:LLY) fell 7.3% after the drugmaker said sales of its Mounjaro and Zepbound weight-loss medications grew more slowly than it had expected. CEO David Ricks said the US
Eli Lilly CEO on prospect of insurance companies covering weight loss drugs
12:45pm, Tuesday, 14'th Jan 2025
Eli Lilly CEO David Ricks discusses the potential of insurance companies covering weight loss drugs saying they will “recognize it's the ultimate prevention medication.”
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
12:11pm, Tuesday, 14'th Jan 2025
Bad news for Eli Lilly (LLY -7.38%) stock dragged down shares of rival companies in the market for GLP-1 diet drugs on Tuesday. Lilly updated investors on its expected revenue for 2024 this morning, a
Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8%
10:53am, Tuesday, 14'th Jan 2025
Eli Lilly saw its shares crash in early trade on Tuesday as the pharm major provided its revenue outlook for 2024 and 2025. The pharma major cut its revenue guidance for the year leading to an around
Lilly's Zepbound and Mounjaro Sales Miss Estimates Again. The Wobble's Looking Serious.
10:46am, Tuesday, 14'th Jan 2025
It was the second consecutive miss for the two closely watched obesity and Type 2 diabetes drugs.
Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs
10:40am, Tuesday, 14'th Jan 2025
Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases insulin levels.
